Compare AISP & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AISP | ECOR |
|---|---|---|
| Founded | 2006 | 2005 |
| Country | United States | United States |
| Employees | 65 | N/A |
| Industry | Blank Checks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 99.9M | 81.0M |
| IPO Year | N/A | 2018 |
| Metric | AISP | ECOR |
|---|---|---|
| Price | $1.98 | $6.14 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $18.00 |
| AVG Volume (30 Days) | ★ 351.8K | 77.7K |
| Earning Date | 05-15-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $32,032,000.00 |
| Revenue This Year | $222.88 | $33.60 |
| Revenue Next Year | $5.36 | $30.40 |
| P/E Ratio | $3.18 | ★ N/A |
| Revenue Growth | N/A | ★ 27.20 |
| 52 Week Low | $1.91 | $4.16 |
| 52 Week High | $7.20 | $10.50 |
| Indicator | AISP | ECOR |
|---|---|---|
| Relative Strength Index (RSI) | 32.23 | 38.55 |
| Support Level | N/A | $5.69 |
| Resistance Level | $2.74 | $7.35 |
| Average True Range (ATR) | 0.10 | 0.66 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 20.27 | 20.48 |
Airship AI Holdings Inc is a robust AI-driven data management platform that solves complex data challenges for large institutions operating in dynamic and mission-critical environments with rapidly increasing volumes of data being ingested from a similarly rapidly growing number of data sources. Its primary offerings include Outpost AI, Acropolis, and Airship Command. Its offerings allow customers to manage their data across the full data lifecycle, when and where need it, using a secure permission-based architecture. Airship AI's software allows customers to view structured data both in real-time as well as to conduct searches on the structured data at a later point in time.
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.